MicroRNAs in muscle wasting.
作者信息
Suzuki Tsuyoshi, Springer Jochen
机构信息
Department of Cardiology and Pneumology, University Medical Center Göttingen (UMG), Göttingen, Germany.
出版信息
J Cachexia Sarcopenia Muscle. 2018 Dec;9(7):1209-1212. doi: 10.1002/jcsm.12384.
Abstract
摘要
相似文献
1
MicroRNAs in muscle wasting.肌肉萎缩中的微小RNA
J Cachexia Sarcopenia Muscle. 2018 Dec;9(7):1209-1212. doi: 10.1002/jcsm.12384.
2
Decreased miR-497-5p Suppresses IL-6 Induced Atrophy in Muscle Cells.miR-497-5p 减少可抑制白细胞介素-6 诱导的肌细胞萎缩。
Cells. 2021 Dec 14;10(12):3527. doi: 10.3390/cells10123527.
3
Cancer cachexia-induced muscle atrophy: evidence for alterations in microRNAs important for muscle size.癌症恶病质诱导的肌肉萎缩：对肌肉大小至关重要的微小RNA改变的证据。
Physiol Genomics. 2017 May 1;49(5):253-260. doi: 10.1152/physiolgenomics.00006.2017. Epub 2017 Mar 24.
4
MicroRNAs as potential therapeutic targets for muscle wasting during cancer cachexia.微小 RNA 作为癌症恶病质肌肉减少症治疗靶点的研究进展。
Curr Opin Clin Nutr Metab Care. 2020 May;23(3):157-163. doi: 10.1097/MCO.0000000000000645.
5
FoxP1 is a transcriptional repressor associated with cancer cachexia that induces skeletal muscle wasting and weakness.FoxP1 是一种与癌症恶病质相关的转录抑制因子，可导致骨骼肌减少和无力。
J Cachexia Sarcopenia Muscle. 2021 Apr;12(2):421-442. doi: 10.1002/jcsm.12666. Epub 2021 Feb 1.
6
Autophagic degradation contributes to muscle wasting in cancer cachexia.自噬降解导致癌性恶病质中的肌肉消耗。
Am J Pathol. 2013 Apr;182(4):1367-78. doi: 10.1016/j.ajpath.2012.12.023. Epub 2013 Feb 8.
7
Cancer-Induced Muscle Wasting Requires p38β MAPK Activation of p300.癌症引起的肌肉减少症需要 p38β MAPK 激活 p300。
Cancer Res. 2021 Feb 15;81(4):885-897. doi: 10.1158/0008-5472.CAN-19-3219. Epub 2020 Dec 22.
8
Involvement of microRNAs in the regulation of muscle wasting during catabolic conditions.微小RNA在分解代谢状态下对肌肉消耗的调节作用。
J Biol Chem. 2014 Aug 8;289(32):21909-25. doi: 10.1074/jbc.M114.561845. Epub 2014 Jun 2.
9
Small-molecule inhibition of MuRF1 attenuates skeletal muscle atrophy and dysfunction in cardiac cachexia.小分子抑制 MuRF1 可减轻心肌恶病质所致的骨骼肌萎缩和功能障碍。
J Cachexia Sarcopenia Muscle. 2017 Dec;8(6):939-953. doi: 10.1002/jcsm.12233. Epub 2017 Sep 8.
10
Impaired regeneration: A role for the muscle microenvironment in cancer cachexia.再生受损：肌肉微环境在癌症恶病质中的作用。
Semin Cell Dev Biol. 2016 Jun;54:82-91. doi: 10.1016/j.semcdb.2015.09.009. Epub 2015 Sep 16.
引用本文的文献
1
The Double-Edged Sword of ROS in Muscle Wasting and COPD: Insights from Aging-Related Sarcopenia.活性氧在肌肉减少症和慢性阻塞性肺疾病中的双刃剑作用：来自与衰老相关的肌肉减少症的见解
Antioxidants (Basel). 2024 Jul 22;13(7):882. doi: 10.3390/antiox13070882.
2
Myogenic microRNAs as Therapeutic Targets for Skeletal Muscle Mass Wasting in Breast Cancer Models.成肌细胞 microRNAs 作为乳腺癌模型中骨骼肌减少症的治疗靶点。
Int J Mol Sci. 2024 Jun 18;25(12):6714. doi: 10.3390/ijms25126714.
3
Review of the endocrine organ-like tumor hypothesis of cancer cachexia in pancreatic ductal adenocarcinoma.胰腺导管腺癌恶病质的内分泌器官样肿瘤假说综述。
Front Oncol. 2022 Nov 17;12:1057930. doi: 10.3389/fonc.2022.1057930. eCollection 2022.
4
MicroRNA profiling of different exercise interventions for alleviating skeletal muscle atrophy in naturally aging rats.不同运动干预缓解自然衰老大鼠骨骼肌萎缩的 microRNA 谱分析。
J Cachexia Sarcopenia Muscle. 2023 Feb;14(1):356-368. doi: 10.1002/jcsm.13137. Epub 2022 Dec 1.
5
MicroRNAs: Novel players in the diagnosis and treatment of cancer cachexia (Review).微小RNA：癌症恶病质诊断与治疗中的新角色（综述）
Exp Ther Med. 2022 May 16;24(1):446. doi: 10.3892/etm.2022.11373. eCollection 2022 Jul.
6
High miR-511-3p Expression as a Potential Predictor of a Poor Nutritional Status in Head and Neck Cancer Patients Subjected to Intensity-Modulated Radiation Therapy.高miR-511-3p表达作为接受调强放疗的头颈癌患者营养状况差的潜在预测指标。
J Clin Med. 2022 Feb 2;11(3):805. doi: 10.3390/jcm11030805.
7
Mechanisms of exercise as a preventative measure to muscle wasting.运动作为预防肌肉减少的措施的机制。
Am J Physiol Cell Physiol. 2021 Jul 1;321(1):C40-C57. doi: 10.1152/ajpcell.00056.2021. Epub 2021 May 5.
8
Regulation of Skeletal Muscle Atrophy in Cachexia by MicroRNAs and Long Non-coding RNAs.微小RNA和长链非编码RNA对恶病质中骨骼肌萎缩的调控
Front Cell Dev Biol. 2020 Sep 15;8:577010. doi: 10.3389/fcell.2020.577010. eCollection 2020.
9
MicroRNAs in Sarcopenia: A Systematic Review.肌肉减少症中的微小RNA：一项系统综述。
Front Med (Lausanne). 2020 May 28;7:180. doi: 10.3389/fmed.2020.00180. eCollection 2020.
10
Non-coding RNAs as Putative Biomarkers of Cancer-Associated Cachexia.非编码RNA作为癌症相关性恶病质的潜在生物标志物
Front Cell Dev Biol. 2020 Apr 21;8:257. doi: 10.3389/fcell.2020.00257. eCollection 2020.
本文引用的文献
1
Regulation of microRNA biogenesis and its crosstalk with other cellular pathways.miRNA 生物发生的调控及其与其他细胞途径的串扰。
Nat Rev Mol Cell Biol. 2019 Jan;20(1):5-20. doi: 10.1038/s41580-018-0059-1.
2
miRNA-23a/27a attenuates muscle atrophy and renal fibrosis through muscle-kidney crosstalk.miRNA-23a/27a 通过肌肉-肾脏相互作用减轻肌肉萎缩和肾纤维化。
J Cachexia Sarcopenia Muscle. 2018 Aug;9(4):755-770. doi: 10.1002/jcsm.12296. Epub 2018 Mar 26.
3
A newly identified lncRNA MAR1 acts as a miR-487b sponge to promote skeletal muscle differentiation and regeneration.一个新鉴定的 lncRNA MAR1 作为 miR-487b 的海绵体促进骨骼肌的分化和再生。
J Cachexia Sarcopenia Muscle. 2018 Jun;9(3):613-626. doi: 10.1002/jcsm.12281. Epub 2018 Mar 7.
4
A muscle-specific MuRF1-E2 network requires stabilization of MuRF1-E2 complexes by telethonin, a newly identified substrate.一种肌特异性 MuRF1-E2 网络需要肌联蛋白稳定 MuRF1-E2 复合物，肌联蛋白是一种新鉴定的底物。
J Cachexia Sarcopenia Muscle. 2018 Feb;9(1):129-145. doi: 10.1002/jcsm.12249. Epub 2017 Dec 22.
5
Circulating myomiRs: a new class of biomarkers to monitor skeletal muscle in physiology and medicine.循环肌微小 RNA：监测生理学和医学中骨骼肌的新型生物标志物。
J Cachexia Sarcopenia Muscle. 2018 Feb;9(1):20-27. doi: 10.1002/jcsm.12227. Epub 2017 Nov 28.
6
Casting the net broader to confirm our imaginations: the long road to treating wasting disorders.广泛撒网以验证我们的设想：治疗消耗性疾病的漫漫征途。
J Cachexia Sarcopenia Muscle. 2017 Dec;8(6):870-880. doi: 10.1002/jcsm.12256.
7
Muscle wasting and sarcopenia in heart failure and beyond: update 2017.心力衰竭及其他疾病中的肌肉减少症和肌少症：2017 年更新
ESC Heart Fail. 2017 Nov;4(4):492-498. doi: 10.1002/ehf2.12237.
8
Trimetazidine restores the positive adaptation to exercise training by mitigating statin-induced skeletal muscle injury.曲美他嗪通过减轻他汀类药物引起的骨骼肌损伤来恢复对运动训练的正向适应。
J Cachexia Sarcopenia Muscle. 2018 Feb;9(1):106-118. doi: 10.1002/jcsm.12250. Epub 2017 Nov 19.
9
The mitochondrial metabolic reprogramming agent trimetazidine as an 'exercise mimetic' in cachectic C26-bearing mice.线粒体代谢重编程剂曲美他嗪在荷瘤 C26 小鼠中作为“运动模拟剂”。
J Cachexia Sarcopenia Muscle. 2017 Dec;8(6):954-973. doi: 10.1002/jcsm.12226. Epub 2017 Nov 11.
10
Ethical guidelines for publishing in the journal of cachexia, sarcopenia and muscle: update 2017.《恶病质、肌肉减少症与肌肉杂志》发表伦理准则：2017 年更新版
J Cachexia Sarcopenia Muscle. 2017 Dec;8(6):1081-1083. doi: 10.1002/jcsm.12261. Epub 2017 Nov 3.
Zotero 插件